期刊
TRENDS IN ENDOCRINOLOGY AND METABOLISM
卷 30, 期 7, 页码 432-444出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tem.2019.04.008
关键词
-
资金
- NIH/NIDDK [RO1 DK051562, RO1 DK 085623, UC4 DK108483]
- University of Virginia Precision Individualized Medicine for Diabetes (PrIMeD) Project
Arguably, diabetes mellitus is one of the best-quantified human conditions: elaborate in silico models describe the action of the human metabolic system; real-time signals such as continuous glucose monitoring are readily available; insulin delivery is being automated; and control algorithms are capable of optimizing blood glucose fluctuation in patients' natural environments. The transition of the artificial pancreas (AP) to everyday clinical use is happening now, and is contingent upon seamless concerted work of devices encompassing the patient in a digital treatment ecosystem. This review recounts briefly the story of diabetes technology, which began a century ago with the discovery of insulin, progressed through glucose monitoring and subcutaneous insulin delivery, and is now rapidly advancing towards fully automated clinically viable AP systems.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据